DE69316023T2 - Stabile zusammensetzung für eine orale dosis mit verlängerter freisetzung - Google Patents

Stabile zusammensetzung für eine orale dosis mit verlängerter freisetzung

Info

Publication number
DE69316023T2
DE69316023T2 DE69316023T DE69316023T DE69316023T2 DE 69316023 T2 DE69316023 T2 DE 69316023T2 DE 69316023 T DE69316023 T DE 69316023T DE 69316023 T DE69316023 T DE 69316023T DE 69316023 T2 DE69316023 T2 DE 69316023T2
Authority
DE
Germany
Prior art keywords
oral dosage
extended release
stable composition
film
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69316023T
Other languages
English (en)
Other versions
DE69316023D1 (de
Inventor
Henry Kwan
Stephen Liebowitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of DE69316023D1 publication Critical patent/DE69316023D1/de
Application granted granted Critical
Publication of DE69316023T2 publication Critical patent/DE69316023T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
DE69316023T 1992-10-23 1993-10-21 Stabile zusammensetzung für eine orale dosis mit verlängerter freisetzung Expired - Lifetime DE69316023T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/965,470 US5314697A (en) 1992-10-23 1992-10-23 Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
PCT/US1993/009873 WO1994009761A1 (en) 1992-10-23 1993-10-21 Stable extended release oral dosage composition

Publications (2)

Publication Number Publication Date
DE69316023D1 DE69316023D1 (de) 1998-02-05
DE69316023T2 true DE69316023T2 (de) 1998-04-23

Family

ID=25510010

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69316023T Expired - Lifetime DE69316023T2 (de) 1992-10-23 1993-10-21 Stabile zusammensetzung für eine orale dosis mit verlängerter freisetzung

Country Status (28)

Country Link
US (1) US5314697A (de)
EP (1) EP0665744B1 (de)
JP (1) JP3580815B2 (de)
KR (1) KR100283709B1 (de)
CN (1) CN1038474C (de)
AT (1) ATE161420T1 (de)
AU (1) AU676229B2 (de)
CA (1) CA2147606C (de)
CZ (1) CZ287687B6 (de)
DE (1) DE69316023T2 (de)
DK (1) DK0665744T3 (de)
EE (1) EE03106B1 (de)
ES (1) ES2110633T3 (de)
FI (1) FI112916B (de)
GR (1) GR3026198T3 (de)
HK (1) HK1004327A1 (de)
HU (1) HU220629B1 (de)
IL (1) IL107354A (de)
MY (1) MY109090A (de)
NO (1) NO308771B1 (de)
NZ (1) NZ257447A (de)
PH (1) PH29940A (de)
PL (1) PL172862B1 (de)
SG (1) SG42947A1 (de)
SK (1) SK281090B6 (de)
TW (1) TW251239B (de)
WO (1) WO1994009761A1 (de)
ZA (1) ZA937830B (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996010996A1 (en) * 1993-07-21 1996-04-18 The University Of Kentucky Research Foundation A multicompartment hard capsule with control release properties
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6676967B1 (en) * 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US7214683B1 (en) 1994-12-30 2007-05-08 Sepracor Inc. Compositions of descarboethoxyloratadine
US7211582B1 (en) 1994-12-30 2007-05-01 Sepracor Inc. Methods for treating urticaria using descarboethoxyloratadine
EP0812195B1 (de) * 1995-02-28 2002-10-30 Aventis Pharmaceuticals Inc. Arzneizubereitungen für piperidinalkanolderivate
US5807579A (en) * 1995-11-16 1998-09-15 F.H. Faulding & Co. Limited Pseudoephedrine combination pharmaceutical compositions
EP0811374A1 (de) 1996-05-29 1997-12-10 Pfizer Inc. Formulierung für ein Kombinationspräparat mit Cetirizin und Pseudoephedrin
TR199901003T2 (xx) * 1996-10-31 1999-07-21 Schering Corporation Ast�m tedavisi i�in loratadin ve bir dekonjestan i�eren bile�im.
TW522014B (en) * 1997-02-07 2003-03-01 Sepracor Inc Lactose-free, non-hygroscopic and anhydrous pharmaceutical unit dosage form containing descarboethoxyloratadine
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
KR100514264B1 (ko) * 1997-08-26 2005-09-15 아벤티스 파마슈티칼스 인크. 피페리디노알칸올-충혈완화제 조합용 제약 조성물
PA8481801A1 (es) * 1998-09-10 2000-09-29 Schering Corp Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando antihistaminas
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
US6051585A (en) * 1998-12-07 2000-04-18 Weinstein; Robert E. Single-dose antihistamine/decongestant formulations for treating rhinitis
KR100505899B1 (ko) * 1999-02-23 2005-08-01 주식회사유한양행 로라타딘과 슈도에페드린을 함유한 캅셀제 조성물
ATE253354T1 (de) * 1999-02-23 2003-11-15 Yuhan Corp Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6100274A (en) * 1999-07-07 2000-08-08 Schering Corporation 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
US6267986B1 (en) * 1999-09-24 2001-07-31 Ranbaxy Laboratories Limited Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine
US6114346A (en) * 1999-10-22 2000-09-05 Schering Corporation Treating sleep disorders using desloratadine
AU2277101A (en) * 1999-12-20 2001-07-03 Schering Corporation Stable extended release oral dosage composition
SK287105B6 (sk) * 1999-12-20 2009-12-07 Schering Corporation Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním
US7147870B2 (en) * 2000-01-13 2006-12-12 Osmotica Corp. Osmotic device containing pseudoephedrine and an H1 antagonist
US6613357B2 (en) * 2000-01-13 2003-09-02 Osmotica Corp. Osmotic device containing pseudoephedrine and an H1 antagonist
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
JP5592042B2 (ja) * 2000-04-14 2014-09-17 ジェイ−メド ファーマシューティカルズ，インコーポレーティッド 鼻炎治療のための単一投与抗ヒスタミン薬／鬱血除去薬製剤
US20020094345A1 (en) * 2000-10-06 2002-07-18 Sara Abelaira Pharmaceutical compositions containing epinastine and pseudoephedrine
WO2002036077A2 (en) * 2000-11-06 2002-05-10 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
CA2450583A1 (en) * 2001-06-20 2003-01-03 Schering Corporation Antihistamines for the treatment of nasal congestion and nasal obstruction
WO2004019917A1 (es) * 2002-08-29 2004-03-11 Osmotica Corp. Dispositivo de liberacion de droga que contiene oseltamivir y un antagonista h1
US6720002B2 (en) 2001-07-20 2004-04-13 R.P. Scherer Technologies, Inc. Antihistamine formulations for soft capsule dosage forms
US6863901B2 (en) 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
US20040051686A1 (en) * 2002-09-17 2004-03-18 Yuan-Sung Weng Carry-on device having functions of both digital photographing and timing
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
US20050013863A1 (en) 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
JP4919801B2 (ja) * 2003-09-26 2012-04-18 アルザ・コーポレーシヨン 高い薬剤配合量を提供する薬剤コーティング及びそれを提供する方法
US20050095288A1 (en) * 2003-11-03 2005-05-05 Andrx Labs, Llc Decongestant and expectorant tablets
CA2547594A1 (en) * 2003-12-01 2005-06-16 Takeda Pharmaceutical Company Limited Method for treatment of solid pharmaceutical preparation prior to printing and solid pharmaceutical preparation subjected to treatment prior to printing
US20050266032A1 (en) * 2003-12-17 2005-12-01 Sovereign Pharmaceuticals, Ltd. Dosage form containing multiple drugs
SE0401031D0 (sv) 2004-04-22 2004-04-22 Duocort Ab A new glucocorticoid replacement therapy
US20060024368A1 (en) * 2004-07-30 2006-02-02 Reza Fassihi Compressed composite delivery system for release-rate modulation of bioactives
AU2005325930B2 (en) * 2005-01-27 2012-01-19 Alembic Limited Extended release formulation of Levetiracetam
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
PE20120075A1 (es) * 2006-06-01 2012-02-20 Merck Sharp & Dohme Composiciones farmaceuticas para la liberacion sostenida de fenilefrina
CN101015519B (zh) * 2007-02-27 2012-03-21 重庆医药工业研究院有限责任公司 一种氯雷他定口服复方药物组合物
WO2008105920A1 (en) * 2007-02-28 2008-09-04 Collegium Pharmaceutical, Inc. Antihistamine combination
US8173637B2 (en) * 2008-07-24 2012-05-08 Handa Pharmaceuticals, Llc Stabilized atypical antipsychotic formulation
EP2448406B1 (de) 2009-02-26 2016-04-20 Relmada Therapeutics, Inc. Oral einnehmbare pharmazeutische zusammensetzungen aus 3-hydroxy-n-methylmorphinan mit verzögerter freisetzung und verwendungsverfahren dafür
CA2690490C (en) 2010-01-19 2012-06-26 Accucaps Industries Limited Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
CN102160859B (zh) * 2011-02-23 2012-11-07 海南斯达制药有限公司 一种氯雷伪麻复方缓释药物
JP5752578B2 (ja) * 2011-12-09 2015-07-22 ジェイ−メド ファーマシューティカルズ，インコーポレーティッド 鼻炎治療のための単一投与抗ヒスタミン薬／鬱血除去薬製剤
CN104983708A (zh) * 2015-06-24 2015-10-21 万特制药(海南)有限公司 一种地氯雷他定硫酸伪麻黄碱缓释片及其制备方法
CN108576895B (zh) * 2018-03-06 2021-04-30 特素生物科技（天津）有限公司 缓释营养主食及其制备方法
EP4188339A1 (de) 2020-07-30 2023-06-07 Faes Farma, S.A. System zur abgabe eines dekongestiven arzneimittels

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282233B1 (en) * 1980-06-19 2000-09-05 Schering Corp Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines
US4601894A (en) * 1985-03-29 1986-07-22 Schering Corporation Controlled release dosage form comprising acetaminophen, pseudoephedrine sulfate and dexbrompheniramine maleate
IE60311B1 (en) * 1987-09-24 1994-06-29 American Home Prod Sustained release etodolac
CN1053570C (zh) * 1987-10-07 2000-06-21 默尔多药物公司 哌啶子基链烷醇的药用组合物-减充血剂复方的制备方法
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine

Also Published As

Publication number Publication date
NO951527L (no) 1995-06-20
CZ287687B6 (en) 2001-01-17
HUT71682A (en) 1996-01-29
DE69316023D1 (de) 1998-02-05
WO1994009761A1 (en) 1994-05-11
EP0665744B1 (de) 1997-12-29
NZ257447A (en) 1996-09-25
PL172862B1 (pl) 1997-12-31
EP0665744A1 (de) 1995-08-09
FI112916B (fi) 2004-02-13
HU9501143D0 (en) 1995-06-28
ZA937830B (en) 1994-04-21
KR100283709B1 (ko) 2001-03-02
CA2147606A1 (en) 1994-05-11
CZ101495A3 (en) 1996-02-14
SK281090B6 (sk) 2000-11-07
US5314697A (en) 1994-05-24
JPH08502516A (ja) 1996-03-19
FI951901A0 (fi) 1995-04-21
DK0665744T3 (da) 1998-09-07
HU220629B1 (hu) 2002-03-28
IL107354A0 (en) 1994-01-25
CA2147606C (en) 2000-10-10
PL308491A1 (en) 1995-08-07
HK1004327A1 (en) 1998-11-20
SG42947A1 (en) 1997-10-17
PH29940A (en) 1996-09-16
GR3026198T3 (en) 1998-05-29
IL107354A (en) 1998-02-08
ES2110633T3 (es) 1998-02-16
CN1089471A (zh) 1994-07-20
NO308771B1 (no) 2000-10-30
SK52295A3 (en) 1997-05-07
NO951527D0 (no) 1995-04-21
AU5405094A (en) 1994-05-24
ATE161420T1 (de) 1998-01-15
FI951901A (fi) 1995-04-21
CN1038474C (zh) 1998-05-27
AU676229B2 (en) 1997-03-06
EE03106B1 (et) 1998-08-17
TW251239B (de) 1995-07-11
JP3580815B2 (ja) 2004-10-27
MY109090A (en) 1996-11-30
KR950703937A (ko) 1995-11-17

Similar Documents

Publication Publication Date Title
DE69316023T2 (de) Stabile zusammensetzung für eine orale dosis mit verlängerter freisetzung
ATE128355T1 (de) Mischungen gegen husten/erkältungen mit gehalt an nichtsedierenden antihistaminika.
MXPA00013037A (es) Composicion estable para dosis oral de liberacion extendida.
ATE79549T1 (de) Nicht-sedative antihistaminica enthaltende husten-/schnupfenmittel.
ATE72989T1 (de) Mischungen gegen husten und/oder erkaeltungen mit gehalt an nichtsteroiden entzuendungshemmenden arzneimitteln.
MX9203278A (es) Pastilla de liberacion sustentada que comprende loratadina, ibuprofen y pseudoefedrina.
NO960067L (no) Nytt farmasöytisk preparat
DK372786A (da) Farmaceutiske praeparater af phenindamin (2,3,4,9-tetrahydro-2-methyl-9-phenyl-1h-indeno(2,1-c)pyridin)
DE3869088D1 (de) Pharmazeutische zusammensetzungen.
DE69516671D1 (de) Verbindungen mit analgetischem und lokalanesthetischem effekt
DE69026295D1 (de) Pharmazeutische Zusammensetzung gegen durch Vasokonstriktion hervorgerufene Krankheiten
JO1821B1 (en) New pharmaceutical product

Legal Events

Date Code Title Description
8364 No opposition during term of opposition